Skip to content

H2020HORIZONFP7

Stichting Amsterdam Umc

Country
NLNetherlands
Defence projects
0
Projects, all programmes
311
As coordinator
104
EU contribution (CORDIS)
EUR 206,250,417
Active
2011 to 2026

Projects

311 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
PROPHETA PeRsOnalized Prevention roadmap for the future HEalThcareHORIZON2022ParticipantEUR 186,250
eBRAIN-HealtheBRAIN-Health - Actionable Multilevel Health DataHORIZON2022ParticipantEUR 447,125
CLASSICAVALIDATING AI IN CLASSIFYING CANCER IN REAL-TIME SURGERYHORIZON2022ParticipantEUR 310,000
INVASIIONINnoVAtive Solution for Imaging of Infiltrating mONocytesHORIZON2022CoordinatorEUR 203,464
irecsimproving Research Ethics Expertise and Competences to Ensure Reliability and Trust in ScienceHORIZON2022ParticipantEUR 407,625
NIMICRYPoor Prognosis Colorectal Cancers Display Self-sustained Growth by Niche-mimicryHORIZON2022CoordinatorEUR 1,949,358
TRIPTRAINING IN TRANSLATIONAL PROTOCOLS FOR MINIMAL INVASIVE DIAGNOSIS AND THERAPY IN PANCREATICO-BILIARY CANCERSHORIZON2022ParticipantEUR 122,268
CANCERNARNA PROCESSING FOR ANTI-CANCER IMMUNOTHERAPYHORIZON2022ParticipantEUR 482,145
MOREMoral residue - epistemological ramifications, ethical implications and didactic opportunitiesHORIZON2022ParticipantEUR 166,040
NADISNAD+ International Scientist-trainingHORIZON2022CoordinatorEUR 823,111
GUTVIBRATIONSGUT VIrus BRain Axis Technology In OrgaNoid ScienceH20202021CoordinatorEUR 2,187,375
PREGBRAINPregnancy and the Human Brain: A Window of NeuroplasticityH20202021CoordinatorEUR 1,500,000
EndoConnectEU Training Network in understanding the molecular regulation and the role of endo-lysosomal processes in cardio-metabolic diseasesH20202021ParticipantEUR 265,620
STOPSTORMA PROSPECTIVE EUROPEAN VALIDATION COHORT FOR STEREOTACTIC THERAPY OF RE-ENTRANT TACHYCARDIAH20202021ParticipantEUR 179,813
ELECTRICEfficacy of Leveraging Endocrine Therapies for Renoprotection during Intensive CareH20202021CoordinatorEUR 277,260
MacrophageEGREgr1 and Egr2 regulate opposite transcriptional programs in macrophagesH20202021CoordinatorEUR 175,572
ALISEAnti-Cancer Light-Controllable Antibody-Peptide ConjugatesH20202021ParticipantEUR 64,400
PRISM 2Psychiatric Ratings using Intermediate Stratified Markers 2H20202021ParticipantEUR 436,870
TAU-NOWTau Pathology in Alzheimer’s disease: Spreading and ResilienceH20202021ParticipantEUR 639,808
Health CASCADEEvidence-based co-creation methodology for bridging the implementation gap between knowledge and action in health promotion.H20202021ParticipantEUR 796,860

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.